Welcome to the international HTA database
Showing [16381 Records] Selected Records [0 Hits] [Clear]
Year | Source | Title | |
---|---|---|---|
1997 | University HealthSystem Consortium (UHC) | Peripheral blood progenitor cell transplantation | |
1997 | VA Technology Assessment Program (VATAP) | Shared decision-making programs: a descriptive analysis of experience with shared decision-making programs in VA. A systematic review: assessing the effectiveness of shared decision-making programs for prostate care | |
1997 | VA Technology Assessment Program (VATAP) | Stereotactic radiosurgery for metastases to the brain: a systematic review of published studies of effectiveness | |
1997 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Coronary stents: clinical experience and cost-effectiveness - nonsystematic review | |
1997 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Guidelines for economic evaluation of pharmaceuticals: Canada (2nd edition) | |
1997 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Troglitazone for Type II diabetes | |
1997 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part I. Evaluation of the clinical literature | |
1997 | University HealthSystem Consortium (UHC) | Red blood cell transfusion guidelines | |
1997 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | An analysis of the use of fluoroquinolones for uncomplicated urinary tract infections, prostatitis and community acquired pneumonia - systematic review | |
1997 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Catalan register of medical technology equipment | |
1997 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Inhaled nitric oxide therapy | |
1997 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Efficacy and safety of thrombolytic treatment in pulmonary thromboembolism | |
1997 | Health Services Utilization and Research Commission (HSURC) | Reducing non-urgent use of the emergency department: a review of strategies and guide for future research | |
1997 | Health Council of the Netherlands Gezondheidsraad (GR) | Gene therapy | |
1997 | Australian Health Technology Advisory Committee (AHTAC) | Review of nucleic acid amplification technology | |
1997 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The efficacy of tacrine and the measurement of outcomes in Alzheimer's disease | |
1997 | Scottish Health Purchasing Information Centre (SHPIC) | Dexfenfluramine in obesity [Briefing note] | |
1997 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | HMG-CoA reductase inhibitors: a review of published clinical trials and pharmacoeconomic evaluations - nonsystematic review | |
1997 | Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) | Duchenne and Becker muscular dystrophies: family screening and molecular diagnosis - nonsystematic review | |
1997 | Australian Health Technology Advisory Committee (AHTAC) | Colorectal cancer screening | |
1997 | Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) | Evaluation of the risks and benefits of early postpartum discharge - systematic review | |
1997 | Australian Health Technology Advisory Committee (AHTAC) | Coronary stenting: a literature review | |
1997 | Australian Health Technology Advisory Committee (AHTAC) | Ambulatory blood pressure monitoring: a literature review | |
1996 | VA Technology Assessment Program (VATAP) | Positron emission tomography | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Ceredase in the treatment of type 1 Gaucher's disease | |
1996 | Finnish Office for Health Care Technology Assessment (Finohta) | Telemedicine applications in Finland 1996 | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Cognitive behavioural therapy in the treatment of chronic fatigue syndrome | |
1996 | Finnish Office for Health Care Technology Assessment (Finohta) | A model for the assessment of telemedicine and a plan for testing of the model within five specialities | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Pallidotomy for Parkinson's disease | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Alpha interferon in the treatment of chronic myeloid leukaemia | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Prestorage filtration of blood components for patients who are chronically transfusion dependent | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Goserelin or other gonadotrophin releasing hormone (GnRH) analogues in the treatment of advanced prostate cancer | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Implantable infusion devices (IIPs) for long-term pain management | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Paclitaxel as a first line chemotherapy agent in the treatment of ovarian cancer | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Growth hormone in children (for growth hormone deficiency, Turner's syndrome, chronic renal failure and idiopathic short stature) | |
1996 | Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) | Routine pre-operative investigation | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Factor V Leiden screening in oral contraceptive users | |
1996 | Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) | Electronic fetal monitoring | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | 5-fluorouracil (5-FU) as adjuvant chemotherapy in Duke's stage C colorectal cancer | |
1996 | Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) | Autologous target cytokines | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Extracorporeal membrane oxygenation for term neonates with severe respiratory failure | |
1996 | Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) | Electromagnetic prostatectomy | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Screening for hepatitis B in pregnancy | |
1996 | Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) | Spinal cord stimulation | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Laser trabeculoplasty as primary therapy for glaucoma | |
1996 | Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) | Stereostatic surgery | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Copolymer 1 in relapsing-remitting multiple sclerosis | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Zafirlukast (Accolate) in asthma | |
1996 | Wessex Institute for Health Research and Development (WIHRD) | Evening primrose oil for cyclical mastalgia | |
1996 | Health Council of the Netherlands Gezondheidsraad (GR) | Assisted fertilization: ICSI | |
1996 | Health Council of the Netherlands Gezondheidsraad (GR) | Marihuana as medicine | |
1996 | Health Council of the Netherlands Gezondheidsraad (GR) | Risk is more than just a number | |
1996 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | A therapeutic and economic assessment of Betaseron in multiple sclerosis - systematic review | |
1996 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | A pharmacoeconomic evaluation of DNAse use in cystic fibrosis -summary | |
1996 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Efficacy, effectiveness and cost-analysis of nitrate therapy for the prevention of angina pectoris | |
1996 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Economic evaluation of alternative therapies in the long term management of peptic ulcer disease and gastroesophageal reflux disease | |
1996 | Alberta Heritage Foundation for Medical Research (AHFMR) | The use of electrical stimulation to promote healing of fractures | |
1996 | Alberta Heritage Foundation for Medical Research (AHFMR) | Availability of thrombolytic therapy in the emergency room | |
1996 | Alberta Heritage Foundation for Medical Research (AHFMR) | Cord blood transplantation | |
1996 | Alberta Heritage Foundation for Medical Research (AHFMR) | Scanning laser ophthalmoscope for diagnosis and monitoring of glaucoma | |
1996 | Alberta Heritage Foundation for Medical Research (AHFMR) | Phalloplasty in female-male transsexuals | |
1996 | Alberta Heritage Foundation for Medical Research (AHFMR) | Bladder ultrasound scanning for the measurement of post-void residual urine volume | |
1996 | The Swedish Council on Health Technology Assessment (SBU) | Effectiveness of bone density measurement and associated terms for prevention of fractures - Statement of finding (CRD Joint Project) | |
1996 | The Swedish Council on Health Technology Assessment (SBU) | Background paper one. Methods used in the measurement of bone density (INAHTA Joint Project) | |
1996 | The Swedish Council on Health Technology Assessment (SBU) | Background paper two. Predictive value of bone densitometry (INAHTA Joint Project) | |
1996 | The Swedish Council on Health Technology Assessment (SBU) | Background paper three. A review of the evidence of hormone replacement therapy and calcitonin in reducing bone loss and fractures (INAHTA Joint Project) | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Beam and isotope radiotherapy | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Minimal access surgery | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Pancreas transplantation | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Prostate cancer screening (consumer statement) | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Prostate cancer screening (executive summary) | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Prostate cancer screening (technical report) | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Superspeciality service guidelines for adult heart transplantation services | |
1996 | Health Services Utilization and Research Commission (HSURC) | Prenatal ultrasound | |
1996 | Basque Office for Health Technology Assessment (OSTEBA) | Bone density measurement and treatments of osteoporosis (INAHTA project) | |
1996 | Scottish Health Purchasing Information Centre (SHPIC) | Surfactant in premature births | |
1996 | Scottish Health Purchasing Information Centre (SHPIC) | Leg ulcers | |
1996 | British Columbia Office of Health Technology Assessment (BCOHTA) | Critical appraisal criteria for clinical practice guidelines | |
1996 | VA Technology Assessment Program (VATAP) | Transferring managed care principles to VHA | |
1996 | VA Technology Assessment Program (VATAP) | Assessing diagnostic technologies | |
1996 | Australian Health Technology Advisory Committee (AHTAC) | Review of magnetic resonance imaging (MRI) | |
1996 | Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) | The potential risks of transmission or Creutzfeldt-Jakob disease associated with the reuse of single-use catheters and permanent pacemakers - nonsystematic review | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Health products comparison: intraocular lenses | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Review of the scientific evidence of commercial products based on electromagnetic fields | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Endocyclodestruction with ophthalmologic laser microendoscope | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Breast cancer screening in Catalonia: cost-effectiveness, health care impact and cost of the treatment of breast cancer | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Cardiac pacemakers, electrodes and cardioverter defibrillators: health products comparison. 3 vols | |
1996 | Basque Office for Health Technology Assessment (OSTEBA) | The prioritisation of evaluation topics of health - primary research | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Health products comparison: accessories for eye surgery | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Transmyocardial revascularization with laser | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Systemic thrombolytics in acute ischemic stroke | |
1996 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Meta-analysis and economic evaluation of sumatriptan for migraine | |
1996 | Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) | Phototherapeutic keratectomy with excimer laser | |
1996 | Scottish Health Purchasing Information Centre (SHPIC) | Antenatal steroids and surfactant in premature births. Summary | |
1996 | Scottish Health Purchasing Information Centre (SHPIC) | Riluzole for motor neurone disease. Briefing note | |
1996 | Scottish Health Purchasing Information Centre (SHPIC) | Lipid-lowering interventions. Summary for general practitioners | |
1996 | University of York | Management of cataract | |
1996 | Scottish Health Purchasing Information Centre (SHPIC) | Preventing blindness in diabetes. Briefing note | |
1996 | University of York | Preventing falls and subsequent injury in older people | |
1996 | Scottish Health Purchasing Information Centre (SHPIC) | Dyspepsia, peptic ulcer and helicobacter pylori. Summary |